Gene Biotherapeutics, Inc. (CRXM)

CRXM Revenue CAGR

Gene Biotherapeutics, Inc. (CRXM) has a revenue compound annual growth rate of -23.50% over 5 years and -31.14% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.